Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro. 1990

J F Manischewitz, and G V Quinnan, and H C Lane, and A E Wittek
Laboratory of Herpesvirus Research, Food and Drug Administration, Bethesda, Maryland 20892.

Ganciclovir and foscarnet possess substantial activity against cytomegalovirus. Both exhibit dose-limiting toxicity, which reduces their clinical usefulness. We demonstrated synergistic inhibition of cytomegalovirus replication in vitro by ganciclovir and foscarnet. Reduced-dose combination therapy may provide a means to treat patients with cytomegalovirus infection while reducing drug toxicity.

UI MeSH Term Description Entries
D010746 Phosphonoacetic Acid A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent. Phosphonoacetate,Disodium Phosphonoacetate,Fosfonet Sodium,Phosphonacetic Acid,Phosphonoacetate, Disodium
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015774 Ganciclovir An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. BIOLF-62,BW-759,Cytovene,Ganciclovir Sodium,Ganciclovir, Monosodium Salt,Gancyclovir,RS-21592
D017245 Foscarnet An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV. Phosphonoformate,Phosphonoformic Acid,Foscarnet Barium (2:3) Salt,Foscarnet Calcium (2:3) Salt,Foscarnet Disodium Salt,Foscarnet Magnesium (2:3) Salt,Foscarnet Manganese (2+) (2:3) Salt,Foscarnet Sodium,Foscarnet Sodium Hexahydrate,Foscarnet Trilithium Salt,Foscarnet Tripotassium Salt,Foscarnet Trisodium Salt,Foscavir,Trisodium Phosphonoformate

Related Publications

J F Manischewitz, and G V Quinnan, and H C Lane, and A E Wittek
January 2016, Antiviral research,
J F Manischewitz, and G V Quinnan, and H C Lane, and A E Wittek
January 1990, Scandinavian journal of infectious diseases. Supplementum,
J F Manischewitz, and G V Quinnan, and H C Lane, and A E Wittek
August 1992, Lancet (London, England),
J F Manischewitz, and G V Quinnan, and H C Lane, and A E Wittek
October 1996, Journal of the National Medical Association,
J F Manischewitz, and G V Quinnan, and H C Lane, and A E Wittek
August 1991, Lancet (London, England),
J F Manischewitz, and G V Quinnan, and H C Lane, and A E Wittek
January 1992, Journal of acquired immune deficiency syndromes,
J F Manischewitz, and G V Quinnan, and H C Lane, and A E Wittek
July 1991, Lancet (London, England),
J F Manischewitz, and G V Quinnan, and H C Lane, and A E Wittek
July 1991, Transplantation,
J F Manischewitz, and G V Quinnan, and H C Lane, and A E Wittek
March 2001, American journal of ophthalmology,
Copied contents to your clipboard!